The challenges in obesity research are significant, but the opportunities for innovation are equally profound.
Matt Wilson
Advertisement
Founder and CEO, uMed
Articles by Matt Wilson
Advertisement
Latest Updated Articles
The Future of Obesity Pharmacology: Bridging Evidence Gaps with a New Model for Clinical RegistriesPublished: October 14th 2024 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform
2
FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
3
Novo Nordisk Enters $4.7 Billion Definitive Agreement with Akero Therapeutics
4
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics
5
